The FDA pushed ahead OSI Pharmaceuticals' anti-cancer drug for use in later stages of lung cancer that do not respond to chemotherapy. But an advisory committee is meeting today over a review saying AstraZeneca's rival drug "unequivocally failed" to work in combination with chemotherapy.
Current research on the topic hones in on using electrical impulses to send visual messages to the brain. New studies, however, are under way to use retinal implants that release chemicals to stimulate nerve signals to the brain. Experiments on animals are still a year away.
Manic depression can be controlled with drugs, but the American Psychiatric Association says many of the more than one in 100 Americans afflicted are not treated. Behavioral changes have also been found to keep manic episodes from occurring.
Proxima Therapeutics' MammoSites is developed specifically for breast brachytherapy, a novel way to target breast tumors with internal radiation. The FDA yesterday approved the device, which cuts radiation treatments from seven weeks to five days.